Adonis key facts
as of Oct 2026- Developer of healthcare revenue intelligence and automation platform designed to streamline revenue cycle management and optimize financial success for medical providers.
- Adonis is valued at approximately $328.0M as of Oct 2026 (last reported valuation).
- It has raised $93.9M; the latest was Later Stage VC ($40.0M) in Mar 2026.
- Notable investors include General Catalyst, Soma Capital, Everywhere Ventures, Correlation Ventures, Point72 Ventures — 20 tracked in total.
- Status: Privately Held (backing).
Adonis's last reported valuation, Mar 2026. Nothing priced has surfaced since.
- ·The complete investor list: 20 names
- ·Watch Adonis: the Monday email on marks, rounds and moves
Adonis funding rounds
No funding rounds for Adonis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Adonis
20+Adonis valuation
Adonis's last reported valuation was $328 million in Mar 2026. No priced round, secondary trade or fund mark has surfaced since.
Adonis investors
20 investors are on record for Adonis, including General Catalyst, Soma Capital, Everywhere Ventures and Correlation Ventures. By type, the record holds 8 venture capital firms, 1 family office and 1 private equity firm.
About Adonis
Developer of healthcare revenue intelligence and automation platform designed to streamline revenue cycle management and optimize financial success for medical providers. The company's platform leverages AI and data-driven insights to automate tasks, detect underpayments and improve claim accuracy, enabling customers to maximize revenue collection, minimize administrative burden and focus on delivering patient care.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 185
- Website
- adonis.io/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.